Abstract
This is a review of the most current literature on the evaluation and management of the urinary system after spinal cord injury (SCI). Spinal cord injury virtually always results in some degree of neurogenic bladder (NGB) dysfunction. While it is widely accepted that NGB dysfunction is associated with an increased risk of urologic complications, consensus regarding screening for those complications, and medical or surgical management is not widely accepted. Regarding screening for complications, an annual renal ultrasound is an appropriate screening test to assess for renal pathology including stones. General guidelines for urodynamic evaluation in patients with SCI were recently published and do not explicitly recommend routine testing. Regarding NGB complications, neurogenic bladders are most prone to urinary tract infections and stones. Medical, equipment and surgical options are all aimed at decreasing the risk of these complications in SCI patients.
Similar content being viewed by others
Abbreviations
- CIC:
-
clean intermittent catheterization
- CKD:
-
chronic kidney disease
- CMG:
-
cystometrogram
- EMG:
-
electromyography
- GFR:
-
glomerular filtration rate
- MDRD:
-
modification of diet in renal disease
- NGB:
-
neurogenic bladder
- PCNL:
-
percutaneous nephrolithotomy
- SCI:
-
spinal cord injury
- UDS:
-
urodynamics
- UTI:
-
urinary tract infection
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Cameron AP, Wallner LP, Forchheimer MB, et al. Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury. Arch Phys Med Rehabil. 2011;92(3):449–56.
Thietje R, Giese R, Pouw M, et al. How does knowledge about spinal cord injury-related complications develop in subjects with spinal cord injury? A descriptive analysis in 214 patients. Spinal Cord. 2011;49(1):43–8.
•• Winters JC, Dmochowski RR, Goldman HB, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2464–72. These guidelines should be read by anyone involved in the care of patients with lower urinary tract symptoms, including those with neurogenic bladder. While there is a paucity of well supported research to support the guidelines, they do provide clinical parameters for some aspects of testing. Overall, urodynamic testing is largely in the hands of the practicing urologists to perform tests that will add to diagnosis, prognosis and surgical planning.
Bellucci CH, Wollner J, Gregorini F, et al. Acute spinal cord injury–do ambulatory patients need urodynamic investigations? J Urol. 2013;189(4):1369–73.
Akkoc Y, Cinar Y, Kismali E. Should complete and incomplete spinal cord injury patients receive the same attention in urodynamic evaluations and ultrasonography examinations of the upper urinary tract? Int J Rehabil Res. 2012;35(2):178–80.
Pannek J, Bartel P, Gocking K, Frotzler A. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy? World J Urol. 2013;31(3):659–64.
•• Fischer MJ, Krishnamoorthi VR, Smith BM, et al. Prevalence of chronic kidney disease in patients with spinal cord injuries/disorders. Am J Nephrol. 2012;36(6):542–8. This publication shows that the recently validated SCI/D correction factor for the MDRD should be used in order to accurately assess SCI patient renal function.
Chikkalingaiah KB, Grant ND, Mangold TM, et al. Performance of simplified modification of diet in renal disease and Cockcroft-Gault equations in patients with chronic spinal cord injury and chronic kidney disease. Am J Med Sci. 2010;339(2):108–16.
•• Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187(2):391–7. This article shows that we still have a long way to go with regard to our understanding of ideal urologic surveillance in the SCI patient.
Tsai SJ, Ting H, Ho CC, Bih LI. Use of sonography and radioisotope renography to diagnose hydronephrosis in patients with spinal cord injury. Arch Phys Med Rehabil. 2001;82(1):103–6.
Ramsey S, McIlhenny C. Evidence-based management of upper tract urolithiasis in the spinal cord-injured patient. Spinal Cord. 2011;49(9):948–54.
Gnessin E, Mandeville JA, Handa SE, Lingeman JE. Changing composition of renal calculi in patients with musculoskeletal anomalies. J Endourol. 2011;25(9):1519–23.
• Welk B, Fuller A, Razvi H, Denstedt J. Renal stone disease in spinal-cord-injured patients. J Endourol. 2012;26(8):954–9.
Wolfe T, Klausner AP, Goetz LL, et al. Ureteroscopy with laser lithotripsy for urolithiasis in the spinal cord injury population. Spinal Cord. 2013;51(2):156–60.
Knox ML, Cantor AM, Bryant JE, Burns JR. Predictive factors for percutaneous nephrolithotomy outcomes in neurogenic bladder population. J Endourol. 2012;26(7):823–7.
•• Wyndaele JJ, Brauner A, Geerlings SE, et al. Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int. 2012;110(11 Pt C):E910–7. This is an excellent review about what we really know regarding UTI prevention and diagnosis and the relationship with catheters in SCI patients. This also highlights guidelines from the European Association of Urology.
Jamison J, Maguire S, McCann J. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database Syst Rev. 2011;12, CD004375.
Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6.
Prasad A, Cevallos ME, Riosa S, et al. A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord. 2009;47(7):565–9.
•• Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63. These comprehensive guidelines address one of the most critical aspects of UTI evaluation and management in the SCI patient.
Bermingham SL, Hodgkinson S, Wright S, et al. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ. 2013;346:e8639.
Li L, Ye W, Ruan H, et al. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2013;94(4):782–7.
Domurath B, Kutzenberger J, Kurze I, Knoth HS. Clinical evaluation of a newly developed catheter (SpeediCath Compact Male) in men with spinal cord injury: residual urine and user evaluation. Spinal Cord. 2011;49(7):817–21.
Chartier-Kastler E, Lauge I, Ruffion A, et al. Safety of a new compact catheter for men with neurogenic bladder dysfunction: a randomised, crossover and open-labelled study. Spinal Cord. 2011;49(7):844–50.
Cameron AP, Clemens JQ, Latini JM, McGuire EJ. Combination drug therapy improves compliance of the neurogenic bladder. J Urol. 2009;182(3):1062–7.
Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol. 2012;62(5):816–30.
Madersbacher H, Murtz G, Stohrer M. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord. 2013;51(6):432–41.
Sanford M. Mirabegron: a review of its use in patients with overactive bladder syndrome. Drugs. 2013.
Athanasopoulos A, Gyftopoulos K, McGuire EJ. Treating stress urinary incontinence in female patients with neuropathic bladder: the value of the autologous fascia rectus sling. Int Urol Nephrol. 2012;44(5):1363–7.
Pannek J, Bartel P, Gocking K. Clinical usefulness of the transobturator sub-urethral tape in the treatment of stress urinary incontinence in female patients with spinal cord lesion. J Spinal Cord Med. 2012;35(2):102–6.
Colli J, Lloyd LK. Bladder neck closure and suprapubic catheter placement as definitive management of neurogenic bladder. J Spinal Cord Med. 2011;34(3):273–7.
Khavari R, Fletcher SG, Liu J, Boone TB. A modification to augmentation cystoplasty with catheterizable stoma for neurogenic patients: technique and long-term results. Urology. 2012;80(2):460–4.
Rowley MW, Clemens JQ, Latini JM, Cameron AP. Simple cystectomy: outcomes of a new operative technique. Urology. 2011;78(4):942–5.
Gurung PM, Attar KH, Abdul-Rahman A, et al. Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10 years of follow-up. BJU Int. 2012;109(8):1236–42.
Johnston L, Cunningham RM, Young JS, et al. Altered distribution of interstitial cells and innervation in the rat urinary bladder following spinal cord injury. J Cell Mol Med. 2012;16(7):1533–43.
Sun Y, Chai TC. Role of purinergic signaling in voiding dysfunction. Curr Bladder Dysfunct Rep. 2010;5(4):219–24.
Munoz A, Somogyi GT, Boone TB, et al. Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptors. BJU Int. 2012;110(8 Pt B):E409–14.
North RA, Jarvis MF. P2X receptors as drug targets. Mol Pharmacol. 2013;83(4):759–69.
Zhang F, Liao L, Ju Y, et al. Neurochemical plasticity of nitric oxide synthase isoforms in neurogenic detrusor overactivity after spinal cord injury. Neurochem Res. 2011;36(10):1903–9.
Kanai A, Zabbarova I, Oefelein M, et al. Mechanisms of action of botulinum neurotoxins, beta3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):300–8.
McCarthy CJ, Zabbarova IV, Brumovsky PR, et al. Spontaneous contractions evoke afferent nerve firing in mouse bladders with detrusor overactivity. J Urol. 2009;181(3):1459–66.
Kanai A, Wyndaele JJ, Andersson KE, et al. Researching bladder afferents-determining the effects of beta(3) -adrenergic receptor agonists and botulinum toxin type-A. Neurourol Urodyn. 2011;30(5):684–91.
Yoo PB, Horvath EE, Amundsen CL, et al. Multiple pudendal sensory pathways reflexly modulate bladder and urethral activity in patients with spinal cord injury. J Urol. 2011;185(2):737–43.
Li P, Liao L, Chen G et al. Early low-frequency stimulation of the pudendal nerve can inhibit detrusor overactivity and delay progress of bladder fibrosis in dogs with spinal cord injuries. Spinal Cord. 2013.
Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473–81.
Compliance with Ethics Guideline
Conflict of Interest
S. Lenherr: none; A. Cameron: received grant from Medtronic.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lenherr, S.M., Cameron, A.P. Voiding Dysfunction and Upper Tract Deterioration after Spinal Cord Injury. Curr Bladder Dysfunct Rep 8, 289–296 (2013). https://doi.org/10.1007/s11884-013-0200-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-013-0200-0